Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

Market Cap	34.17B -16.8%
Revenue (ttm)	4.58B -1.3%
Net Income	1.62B -11.7%
EPS	2.07 -11.7%
Shares Out	785.72M
PE Ratio	21.03
Forward PE	18.29
Dividend	1.20 (2.70%)
Ex-Dividend Date	May 27, 2026

Volume	4,574,241
Open	47.00
Previous Close	44.50
Day's Range	43.08 - 47.00
52-Week Range	43.13 - 71.51
Beta	-0.22
Analysts	Strong Buy
Price Target	64.71 (+48.79%)
Earnings Date	Aug 28, 2026

About SHE:300832

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay analyzers, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,785
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300832

Financial Performance

In 2025, SHE:300832's revenue was 4.58 billion, an increase of 0.91% compared to the previous year's 4.54 billion. Earnings were 1.62 billion, a decrease of -11.39%.